These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26237572)

  • 1. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
    Hendriks WT; Jiang X; Daheron L; Cowan CA
    Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.
    Hendriks WT; Warren CR; Cowan CA
    Cell Stem Cell; 2016 Jan; 18(1):53-65. PubMed ID: 26748756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.
    Soh CL; Huangfu D
    Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.
    Xue H; Wu J; Li S; Rao MS; Liu Y
    Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
    Dettmer R; Naujok O
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gene editing efficiencies of CRISPR/Cas9 and TALEN for generation of MSTN knock-out cashmere goats.
    Zhang J; Liu J; Yang W; Cui M; Dai B; Dong Y; Yang J; Zhang X; Liu D; Liang H; Cang M
    Theriogenology; 2019 Jul; 132():1-11. PubMed ID: 30981084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.
    Li M; Suzuki K; Kim NY; Liu GH; Izpisua Belmonte JC
    J Biol Chem; 2014 Feb; 289(8):4594-9. PubMed ID: 24362028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
    Horii T; Hatada I
    Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.
    Blair JD; Bateup HS; Hockemeyer DF
    J Vis Exp; 2016 Feb; (108):e53583. PubMed ID: 26863600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hPSC gene editing for cardiac disease therapy.
    Saleem A; Abbas MK; Wang Y; Lan F
    Pflugers Arch; 2022 Nov; 474(11):1123-1132. PubMed ID: 36163402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome editing in human stem cells.
    Byrne SM; Mali P; Church GM
    Methods Enzymol; 2014; 546():119-38. PubMed ID: 25398338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
    Yang L; Yang JL; Byrne S; Pan J; Church GM
    Curr Protoc Mol Biol; 2014 Jul; 107():31.1.1-31.1.17. PubMed ID: 24984853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.